World

Lilly experimental ‘triple G’ obesity drug leads to 24.2% weight loss in trial

2023.06.26 18:22


© Reuters. FILE PHOTO: Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo

By Deena Beasley

(Reuters) -Eli Lilly on Monday said a mid-stage trial of its next-generation obesity drug candidate “triple G” showed that it led to weight loss of up to 24.2% after 48 weeks, surpassing results seen with other weight loss drugs.

The once-weekly injected drug, retatrutide, is part of a class known as incretins designed to mimic the action of the GLP-1 hormone, which helps regulate blood sugar, slow stomach emptying and decrease appetite. The new family of drugs has reignited interest in the weight-loss treatment market, which is estimated to reach $100 billion by the end of the decade.

Lilly’s Mounjaro, which is awaiting U.S. regulatory approval for treatment of obesity, targets GLP-1 as well as a second obesity-related hormone called GIP. Retatrutide targets GLP-1, GIP and the body’s receptors for a third hormone, glucagon.

Given the three targets, Lilly has nicknamed the drug triple G.

The company reported last year that a trial of Mounjaro in people who were obese or overweight found it led to weight loss of 22.5% after 72 weeks.

Lilly said the 338-person retatrutide study also showed that the drug helped improve blood pressure and blood sugar levels.

It said side effects were similar to those seen with other incretin-based therapies, including generally mild-to-moderate nausea and vomiting.

Lilly is conducting longer-duration phase 3 trials of retatrutide to see if weight loss might be further improved.

Those studies will evaluate the drug’s safety and effectiveness for chronic weight management as well as obstructive sleep apnea and knee osteoarthritis.

“These phase 2 data have given us confidence to further explore the potential of retatrutide in phase 3 trials that will look beyond weight reduction and focus on treating obesity and its complications comprehensively,” Dan Skovronsky, Lilly’s chief scientific and medical officer, said in a statement.

Results from the phase 2 trial were presented in San Diego at a meeting of the American Diabetes Association and published in the New England Journal of Medicine.

Source link

Related Articles

Back to top button
bitcoin
Bitcoin (BTC) $ 96,353.82 1.69%
ethereum
Ethereum (ETH) $ 3,316.02 2.98%
tether
Tether (USDT) $ 1.00 0.06%
solana
Solana (SOL) $ 246.79 3.90%
bnb
BNB (BNB) $ 649.25 1.70%
xrp
XRP (XRP) $ 1.35 9.87%
dogecoin
Dogecoin (DOGE) $ 0.4129 5.08%
usd-coin
USDC (USDC) $ 1.00 0.27%
cardano
Cardano (ADA) $ 0.978254 8.56%
staked-ether
Lido Staked Ether (STETH) $ 3,316.72 2.97%
tron
TRON (TRX) $ 0.203397 5.37%
avalanche-2
Avalanche (AVAX) $ 39.69 5.67%
the-open-network
Toncoin (TON) $ 5.98 4.61%
shiba-inu
Shiba Inu (SHIB) $ 0.000025 4.61%
wrapped-steth
Wrapped stETH (WSTETH) $ 3,920.25 3.88%
stellar
Stellar (XLM) $ 0.472999 6.32%
wrapped-bitcoin
Wrapped Bitcoin (WBTC) $ 96,007.72 2.11%
polkadot
Polkadot (DOT) $ 8.46 2.30%
chainlink
Chainlink (LINK) $ 16.61 5.57%
bitcoin-cash
Bitcoin Cash (BCH) $ 494.29 3.46%
weth
WETH (WETH) $ 3,316.21 3.19%
sui
Sui (SUI) $ 3.32 4.72%
pepe
Pepe (PEPE) $ 0.00002 6.62%
leo-token
LEO Token (LEO) $ 8.51 1.62%
near
NEAR Protocol (NEAR) $ 6.42 2.16%
litecoin
Litecoin (LTC) $ 93.93 6.75%
aptos
Aptos (APT) $ 11.85 6.49%
uniswap
Uniswap (UNI) $ 10.34 5.25%
wrapped-eeth
Wrapped eETH (WEETH) $ 3,486.35 2.73%
hedera-hashgraph
Hedera (HBAR) $ 0.140274 8.99%
usds
USDS (USDS) $ 1.00 0.28%
internet-computer
Internet Computer (ICP) $ 10.68 7.63%
crypto-com-chain
Cronos (CRO) $ 0.18264 5.28%
polygon-ecosystem-token
POL (ex-MATIC) (POL) $ 0.537589 5.54%
ethereum-classic
Ethereum Classic (ETC) $ 27.71 7.03%
ethena-usde
Ethena USDe (USDE) $ 1.00 0.08%
render-token
Render (RENDER) $ 7.43 5.24%
fetch-ai
Artificial Superintelligence Alliance (FET) $ 1.47 5.91%
kaspa
Kaspa (KAS) $ 0.149397 5.47%
bittensor
Bittensor (TAO) $ 501.52 3.35%
whitebit
WhiteBIT Coin (WBT) $ 24.37 1.44%
dai
Dai (DAI) $ 1.00 0.17%
celestia
Celestia (TIA) $ 7.78 14.64%
arbitrum
Arbitrum (ARB) $ 0.816072 3.35%
bonk
Bonk (BONK) $ 0.000045 8.75%
mantra-dao
MANTRA (OM) $ 3.67 1.41%
filecoin
Filecoin (FIL) $ 5.41 1.82%
cosmos
Cosmos Hub (ATOM) $ 8.27 0.15%
vechain
VeChain (VET) $ 0.039884 8.54%
okb
OKB (OKB) $ 52.31 2.51%